Polaryx Therapeutics, Inc. Common Stock (PLYX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Polaryx Therapeutics, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Valuation | |||
| P/E Ratio | -184.42x | -218.34x | -1753.91x |
| P/B Ratio | 362.98x | 1406.63x | 5190.32x |
| P/S Ratio | 0.00x | 0.00x | 0.00x |
| Profitability | |||
| Gross Margin | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% |
| Liquidity | |||
| Current Ratio | 8.55x | 17.30x | 2.23x |
| Quick Ratio | 8.55x | 17.30x | 2.23x |
| Leverage | |||
| Debt/Equity | 0.00x | 0.00x | 0.10x |
YoY = year-over-year change. Source: FMP..